ArticleFrontiers in oncology2025
Subregional CT radiomics for preoperative prediction of mitotic index and risk stratification in 2-5 cm gastrointestinal stromal tumors of the stomach: a dual-center study.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To propose a model based on computed tomography (CT) subregional radiomics to predict the preoperative mitotic index of 2-5 cm Gastrointestinal Stromal Tumors (GISTs) of the stomach. Materials and methods: This retrospective study enrolled a total of 368 patients with GISTs from two institutions: Center 1 comprised 239 patients (122 M, 117 F; mean age 61.66 ± 10.86 years), and Center 2 comprised 129 patients (51 M, 78 F; mean age 60.28 ± 9.72 years). Radiomics features were extracted from the entire tumor. Concurrently, k-means clustering was applied to imaging features to define three distinct tumor subregions, from which radiomics features were subsequently extracted. The Recursive Feature Addition method was used to identify features correlated with the mitotic index in patients with 2-5 cm gastric GISTs. Using the selected features from each subregion and the whole tumor, logistic regression (LR) was employed to construct subregion-based radiomics models and conventional whole-tumor-based radiomics models, respectively. Results: Better performance was observed for unenhanced CT subregions 1, 2, and 3 compared with the conventional radiomics model. The area under the receiver operating characteristic curve (AUC), accuracy, sensitivity, and specificity of the model for subregion 3 in the training set were 0.98, 0.97, 0.98, and 0.90, respectively. In the validation and external test sets, the AUC values were 0.874 and 0.804, respectively. The conventional whole-tumor radiomics model based on venous phase CT demonstrated superior performance compared to all subregion-based models, achieving an AUC of 0.956 in the training set, with accuracy, sensitivity, and specificity of 0.94, 0.97, and 0.83, respectively. In the validation and external test sets, it attained AUC values of 0.892 and 0.805, respectively. Conclusion: Subregional CT radiomics may be used to predict the mitotic index of patients with 2-5 cm gastric GIST before surgery. In particular, subregional radiomics models based on unenhanced CT showed excellent predictive performance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.